Current practice guidelines do not recommend dosage reduction of dipeptidyl-peptidase IV inhibitors in people with type 2 diabetes who fast during Ramaḍān (1, 4, 5). The gene discussed is DPP4; the disease is type 2 diabetes mellitus.